Meadow Creek Investment Management’s Adaptive Biotechnologies ADPT Stock Holding History

Meadow Creek Investment Management’s Portfolio ADPT Stock Details ADPT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	$30K	Buy	+980	New	+$40K	﹤0.01%	1292

Other funds holding ADPT

Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return

MCMC

Matrix Capital Management Company Portsmouth, New Hampshire $46.3M AUM 114.38% 1-Year Est. Return

SIG

Senator Investment Group New York $2.18B AUM 58.56% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

Tiger Management New York $22.8M AUM 0.71% 1-Year Est. Return

TCM

TimesSquare Capital Management New York $6.8B AUM 45.85% 1-Year Est. Return

FAM

Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Meadow Creek Investment Management's ADPT Position: Q3 2019 in Review

Meadow Creek Investment Management opened a new position in Adaptive Biotechnologies (ADPT) in Q3 2019: 980 shares worth $30K. The stake represents ﹤0.01% of the portfolio and ranks #1292 among its holdings.

117 funds tracked by Wall St. Rank hold ADPT as of Q3 2019.

Meadow Creek Investment Management held 980 shares of Adaptive Biotechnologies worth $30K as of Q3 2019.
Adaptive Biotechnologies was a new Meadow Creek Investment Management position in Q3 2019.
Adaptive Biotechnologies made up ﹤0.01% of Meadow Creek Investment Management's portfolio in Q3 2019, its #1292 holding.
117 funds tracked by Wall St. Rank held Adaptive Biotechnologies as of Q3 2019.

Based on Meadow Creek Investment Management's 13F filing for Q3 2019, filed 14 Nov 2019.